VLS-1488

· Volastra Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VLS-1488, covering 2025-11-04 to 2025-11-04. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer [Phase 1, Phase 2]